‘Cautious optimism’ – J&J vaccine trials underway

With more than 20 COVID-19 vaccines in clinical trials, the collaboration between Johnson & Johnson and Beth Israel Deaconess in Boston is getting $1 billion in U.S. funding. Lead researcher Dan Barouch charts the road ahead.  Watch Article


Inside 1 lab’s race to create a COVID19 vaccine


Johnson & Johnson’s Coronavirus Vaccine Protects Monkeys, Study Finds

An experimental coronavirus vaccine developed by Johnson & Johnson protected monkeys from infection in a new study. It is the second vaccine candidate to show promising results in monkeys this week. Read Article

Johnson & Johnson sees promising COVID-19 vaccine results after testing on monkeys

The pharmaceutical giant will now begin testing its vaccine candidate on humans. Read Article



Johnson & Johnson starts human study of COVID-19 vaccine after promising monkey data

Johnson & Johnson on Thursday kicked off U.S. human safety trials for its COVID-19 vaccine after releasing details of a study in monkeys that showed its best-performing vaccine candidate offered strong protection in a single dose. Read Article


COVID-19 vaccine developed by Beth Israel, Johnson & Johnson, enters early-stage trials

Dr. Barouch spoke to the Boston Globe about our COVID-19 vaccine developments entering early-stage clinical trial in people. Read Article


The Latest News About a Promising COVID-19 Vaccine Candidate

Lisa Ling speaks with Dr.Dan Barouch, M.D., Ph.D. about the latest findings in preclinical trials about an investigational #COVID19 vaccine published this morning in Nature and why the results are so encouraging. See Article

Vaccines may arrive in record time, but the virus has been faster

Scientists have created candidate vaccines, which eventually could protect billions of people from COVID-19, with astonishing speed, compressing scientific efforts that usually take years into months. But the leader of a key drug trial said Tuesday that the blistering research pace has nonetheless been too slow to catch the coronavirus. Read Article


A covid-19 vaccine can ensure better outcomes for communities of color. Let’s work to earn their trust.

Dr. Kathryn Stephenson co-wrote this OP-ED for the Washington Post. Read Article